Bot to Trot: AI Steps Up to Transform Healthcare

Snow Companies LLC; United Kingdom; On-site; GBP 40,000 - 80,000; Full time

Job summary

An innovative firm is looking for a healthcare marketing professional to leverage AI tools for optimizing workflows and ensuring compliance. This role involves implementing cutting-edge AI solutions to enhance patient engagement while navigating the complexities of regulatory requirements. As the industry evolves, your contributions will play a crucial role in shaping how healthcare marketing adapts to new technologies. Join a forward-thinking team dedicated to improving patient experiences through ethical and effective AI use. If you are passionate about healthcare and technology, this opportunity is perfect for you.

Benefits

Flexible Working Hours

Health Insurance

Professional Development Opportunities

Remote Work Options

Qualifications

• Experience with AI tools in healthcare marketing and compliance.
• Strong understanding of regulatory processes and approvals.

Responsibilities

• Implement AI solutions to optimize healthcare marketing workflows.
• Ensure compliance with medical, legal, and regulatory standards.

Skills

AI Implementation

Healthcare Marketing

Data Analysis

Regulatory Compliance

Education

Bachelor's Degree in Marketing or Related Field

Master's Degree in Healthcare Management

Tools

ClaiMS TM

DrugGPT

Job description

When singer-songwriter Randy Travis survived a near-fatal stroke in 2013, he was left with numerous physical challenges, the cruelest of which was limited singing and speaking ability. Yet earlier this year, his voice could be heard in the new song “Where That Came From.” How? A form of artificial intelligence (AI) specialized in voice cloning used Travis’ voice, as recorded over a decades-long career, to fill in the vocals of the song. This inspiring example shows how AI can help individuals with health conditions make up for deficits they experience.

But the role of AI in healthcare will go beyond this. For years, our colleagues in R&D have successfully implemented AI to discover new molecules, simulate biological processes, and determine optimal clinical trial design. And there’s more to come. As Scott Galloway said so poignantly at a keynote in May: U.S. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world […]. It remains to be seen if AI will make healthcare either less expensive or better at improving people’s health, but there is no doubt that it will be a major part of how the field will evolve.

Every stakeholder is going to be impacted. Patients can look forward to electronic assistance that can return their voice or other lost abilities. […] As we enter into the age of precision medicine, AI will be a critical tool to determine, with the help of disease knowledge graphs, which indications, associations, contraindications, side effects, genetic markers, drug targets, drug carriers, and interactions to take into account on a case-by-case basis. One step in this direction is DrugGPT, a tool that has been rolled out to doctors in the UK. It provides guidance and acts as a safety net for prescribers. When entering a patient’s conditions into the chatbot, it responds with a list of recommended drugs. It also flags possible side effects and interactions between drugs. It’s easy to imagine that prescribers are going to rely more and more on such tools.

Efficiencies with AI

As for healthcare marketers, there are a number of ways AI is starting to optimize our workflows. For example, Claims TM , Omnicom Health Group’s compliance orchestration solution, is designed to be a brand’s “single source of truth.” In other words, Claims TM provides creators access to real-time approved brand claims, references, and safety during initial creative development and actively surveys draft materials throughout the project lifecycle to ensure they align with previously approved content. This promises to accelerate the medical, legal, and regulatory (MLR) process, obtain approvals quicker, and reduce rework cycles. In the patient engagement space, the potential is immense.

Yet from a risk-mitigation perspective, we anticipate a cautious, measured approach by most biopharma companies. The simpler types of AI that rely on approved data libraries or thoroughly vetted scripted user interactions will likely dominate. Most bearers of regulatory responsibility are going to be uncomfortable allowing a generative AI to directly interact with patients. […] The less predictable the tool is, the less likely it will be to obtain approval.

A Bonus for Authenticity

As biopharma professionals begin to routinely implement AI solutions, one thing we should all watch out for is how unique our work outputs are really going to be. If we all use the same models that are trained on the same sets of data, all we’ll see is a race to the middle. True innovation, true thinking outside the box, cannot happen that way. For the foreseeable future, outstanding work will be done only by humans working in conjunction with AI.

The question of authenticity ties in with this: In a world where everything you see, read, and hear is potentially artificially generated, people are likely (or hopefully) becoming more savvy and discerning about the content they consume. Any healthcare marketer who can credibly claim that the patients, stories, and experiences they make accessible are true examples of living with a health condition will be certain to get their audience’s attention.

The story of artificial intelligence can be scary, as in the case of deepfakes, when AI-generated content is passed off as a reflection of reality. It can also be inspiring, as in the case of Randy Travis. It’s up to us to use it transparently and ethically, so that the disruption that is inevitably going to happen is one that improves the way people deal with health conditions.